WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

NHSA Seeks Public Input on 2025 Drug Reimbursement and Innovation List Reform ... The NHSA has released for public consultation a set of draft policy documents outlining the 2025 adjustment framework for the NRDL and a separate list for commercial heal...
(7/1/2025)

FDA's Crackdown and China's Dealmaking: Warnin... (7/2/2025)

Medical Advances Soar With APAC's Clinical Tri... (7/2/2025)

Tracking the Crossroads of Policy, Innovation,... (7/1/2025)

BeOne Launches Phase III Trial Comparing Subcu... (7/1/2025)

China Launches Landmark Measures to Boost Inno... (7/1/2025)

Analyzing Key Trends in China's Patent-Linkage... (6/27/2025)

Fresh Antitrust Guidelines to Address Pharmace... (6/27/2025)

Breaking the Boundaries: A New Map of Physicia... (6/25/2025)

Structuring Cross Border China Biotech 'NewCo'... (6/19/2025)

CDE Annual Report Reveals Strong Growth and Ev... (6/19/2025)

China Emerges as Prime Global Target for Multi... (6/17/2025)

China Proposes Shorter Clinical Trial Reviews ... (6/16/2025)

Vaccine Sales Collapse in China as MNCs ... (7/3/2025) AbbVie's Venclexta Approved in China for... (7/3/2025) Eli Lilly's Tirzepatide Approved in Chin... (7/3/2025) Hengrui Medicine Gains NMPA Approval for... (7/3/2025) CTTQ's Homegrown rFVIIa Wins NMPA Approv... (7/3/2025) Belief BioMed Unveils 4-Year Follow-Up D... (7/3/2025) Cloudbreak Pharma Debuts on HKEX, Raisin... (7/3/2025) Akeso Launches Clinical Trials for First... (7/3/2025) Dizal's Lung Cancer Pill Gains FDA Nod, ... (7/3/2025) CStone Expands Pipeline with Novel BsAb ... (7/3/2025) API China 2025 Ends with High Attendance... (7/2/2025) China to Eliminate CD Submission Require... (7/2/2025) China Issues Technical Guidance for Clin... (7/2/2025) HanchorBio and Henlius Ink Major Licensi... (7/2/2025) InventisBio Launches First Phase III Tri... (7/2/2025) Betta's Tibremciclib Approved in China f... (7/2/2025) NMPA Grants Marketing Approval to GeneSc... (7/2/2025) China Grants Conditional Approval to Beb... (7/2/2025)

China's Pharma Market Faces Mixed Performance in Q1 202... China's Retail Pharmacy Market Hits CNY 941.1B in 2024 ... NH's DB6: China's Consumer Healthcare Market Underperfo... China's Hospital Drug Market Shows Slight Growth in 202... China Unveils Ambitious Plan to Boost Health-Related Co...

CStone Expands Pipeline with Novel BsAb Targeting Autoi... Cloudbreak Pharma Debuts on HKEX, Raising HK$612 Millio... AbbVie's Venclexta Approved in China for Second-Line Tr... Vaccine Sales Collapse in China as MNCs Struggle with L... InventisBio Launches First Phase III Trial of TYK2 Inhi...

China Issues Technical Guidance for Clinical Resistance... China to Eliminate CD Submission Requirement for Clinic... CDE Seeks Feedback on Draft Guidelines for Pharma Chang... CDE Reopens Public Consultation on Revised Technical Gu... CDE Issues the Technical Guidelines for IVRT and IVPT o...

NHSA Seeks Public Input on 2025 Drug Reimbursement and ... China Raises Per Capita Public Health Funding to Suppor... China Issues Guidelines to Promote TCM and Western Medi... China Issues 2025 Action Plan to Combat Malpractice in... NHSA Issues Notice to Enhance Drug Pricing and Procurem...

Record China Pharma Monopoly Fine Sends Strong Deterren... Conjupro Files USPTO Challenge on Ascletis' U.S. Patent... China's Draft National Medical Security Law: Seven Key ... China Releases Draft Medical Security Law for Public Co... Tianjin Slaps CNY 362M Fine for Drug Price-Fixing Sche...

API China 2025 Ends with High Attendance and Global Ind... FDA Issues Warning Letters to Two Chinese API Manufactu... Implications of China's Growing Influence in Global Pha... FDA Issues Warning to Tianjin Darentang for Manufacturi... Shanghai Pharma Considers API Partnerships with Indian ...

Dizal's Lung Cancer Pill Gains FDA Nod, Challenging Riv... Akeso Launches Clinical Trials for First Bispecific ADC Belief BioMed Unveils 4-Year Follow-Up Data for Hemophi... CTTQ's Homegrown rFVIIa Wins NMPA Approval for Bleeding... Hengrui Medicine Gains NMPA Approval for Novel Dry Eye ...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Official and Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Former CFDA Commissioner Bi Jingquan Under Investigati...

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...